Actn2 — Actinin Alpha 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
.infobox.inbox-gene
ACTN2
=== ===
Full Name: Actinin Alpha 2
Chromosome: 1q42.13
NCBI Gene ID: 88
OMIM: 102573
Ensembl ID: ENSG00000143631
UniProt: P35609
=== ===
Associated Diseases: Cardiomyopathy, neuromuscular disorders
Actinin Alpha 2 (ACTN2) is a gene implicated in Cardiomyopathy, neuromuscular disorders.
ACTN2 (Actinin alpha 2) is an actin-binding protein belonging to the spectrin superfamily. While primarily known for its role in skeletal and cardiac muscle, it is also expressed in neurons where it localizes to postsynaptic densities.
In neurons, ACTN2 may play roles in synaptic organization and plasticity. It interacts with synaptic proteins and may contribute to the structural integrity of synapses. ACTN2 contains four EF-hand calcium-binding domains that enable calcium-dependent conformational changes.
While not directly implicated in neurodegeneration, ACTN2 variants can cause cardiomyopathy which may have neurological implications. Research suggests possible roles in synaptic tagging and memory formation.
High expression in skeletal and cardiac muscle. Lower expression in brain, particularly in cortex and hippocampus. In the brain, ACTN2 is primarily localized to excitatory synapses.
ACTN2 forms antiparallel homodimers that crosslink actin filaments. Each subunit contains four EF-hand domains that bind calcium with varying affinity. The N-terminal actin-binding region contains a conserved calponin homology domain.
In neurons, ACTN2 interacts with synaptic proteins including NMDA receptors and PSD-95 family members. It may serve as a scaffolding protein at the postsynaptic density.
Cardiac complications are common in neurodegenerative disease patients, particularly in those with autonomic dysfunction. Understanding ACTN2 variants may help with:
ACTN2 (Alpha-Actinin-2) is primarily expressed in skeletal and cardiac muscle, with lower expression in the brain:
In neurons, ACTN2 interacts with NMDA receptors and PSD-95 to regulate synaptic plasticity and calcium signaling.
ACTN2 modulators are being explored for various applications:
| Approach | Status | Description |
|---|---|---|
| Small molecule stabilizers | Research | Compounds that enhance ACTN2-actin binding |
| Gene therapy | Preclinical | AAV-mediated ACTN2 expression for cardiac disease |
| Peptide inhibitors | Research | Blocking ACTN2-protein interactions |
The study of Actn2 — Actinin Alpha 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.